FundingHealthcare & Life Sciences
Sofina set to lead PlatinumRx $32 million round
By Abha Lohia · Editor ·
BengaluruFounded 2023
- PlatinumRx is a Bengaluru-based online pharmacy selling medicines, including cheaper substitute options, through its app and website
- Belgian investor Sofina is set to lead a funding round of about $32 million in the company
- The deal reportedly values PlatinumRx at about $200 million
What happened
- Sofina is set to lead a $32 million round.
- The valuation is about $200 million.
Why it matters
- Online pharmacy is a crowded space in India.
The business
- PlatinumRx sells medicines online.
- It is run by Afforis Health Technologies.
Who put in money
- Sofina Lead
The numbers around it
Healthcare & Life Sciences in November 2026: 5 rounds with a disclosed amount, $48.7 million in all; the biggest was PlatinumRx ($32M). Every sector this year →
Read next
LaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugarFundingSuperhealth swaps lead investor in ₹100 crore raiseSuperhealth runs hospitals built around fixed-price procedures and a zero-commission model for doctors, with its first site in BengaluruLaunchPopVax builds open personalised cancer vaccinePopVax is a Hyderabad biotech company that designs mRNA vaccines, with its own RNA Foundry for making them
All startup news on 12 November 2026 →
Is this PlatinumRx? Get your “Featured on StopDown” badge →